This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 27 Aug 2019  |  North America

    Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024

    Digital Solutions will Spark Integrated Development Approaches and Successful Adjunctive Therapies for Disease Modification

    As one lives longer, one needs to increasingly battle age-related disorders. Neurodegenerative disorders are the most worrisome, because they impact millions of people around the world and lack any curative therapy. While companies continue their search, they are also battling declining revenues from marketed products used to manage symptoms. Heavy...

    $4,950.00
  2. 23 Aug 2019  |  South Asia, Middle East & North Africa

    Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020

    Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020

    In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...

    $4,950.00
  3. 25 Jun 2019  |  Global

    Technologies Transforming the Biomanufacturing Landscape

    Translating Technology Innovation to Market Competitiveness

    Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...

    $4,950.00
  4. 07 Jun 2019  |  Asia Pacific

    Growth Insights in APAC Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2023

    The Rising Prevalence of TB, HIV, and Hepatitis, Accompanied by the Development of Portable POCT Devices will Propel the APAC Infectious Diseases POCT Market

    This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

    $3,000.00
  5. 28 May 2019  |  North America

    Growth Insights on the US In vitro Fertilization Services Market, 2018

    Innovative Fertility-as-a-Service Business Models and the Increase in IVF being Offered as an Employment Perk, and the Rise in Egg-freezing Cycles will Accelerate Growth in the Market

    Today, the journey of starting a family does not look the way it did fifty years ago, and people are turning to fertility services for help. 1 in 8 couples in the United States experience pregnancy-related difficulties that fertility treatments can address. Key market drivers include the increasing rate of obesity causing deterred ovulation in wom...

    $3,000.00
  6. 30 Apr 2019  |  Global

    Technological Advances Enabling Stem Cells Reprogramming

    Technologies Paving New Avenues to Drive Breakthrough Research Toward the Discovery of Next Generation Therapeutics

    Since the advent of stem cells reprogramming after the discovery of the differentiation factors that allow the creation of human induced pluripotent stem cells, researchers all around the world are strongly committed to develop novel methods to design and build human stem cells. Indeed, there is an increasing demand for the more efficient product...

    $4,950.00
  7. 25 Apr 2019  |  North America

    Growth Opportunities in Global Vaccines Market, Forecast to 2024

    Increased Investment in Adult Immunization and Improved Mammalian Cell-culture Expression Systems will Drive Growth and Profitability

    The report provides an overview of the global vaccine market estimating the market size broken down by different segments. Vaccines, though a sub-set of biologics, have a completely different dynamic. Not only are they largely designed for a healthy cohort but are also exponentially influenced by government actions and policies. While old generatio...

    $4,950.00
  8. 11 Apr 2019  |  North America

    Pharma Clinical Trial Digitization—Companies to Action, 2019

    Collision of Healthcare with Life Sciences IT Systems will Continue to Transform the Clinical Trials Market

    Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-cent...

    $1,500.00
  9. 10 Apr 2019  |  Africa

    Generic Pharmaceutical Market in Kenya and Nigeria, Forecast to 2022

    Greater Regulatory Control and a Shift of Focus Away from Costly and Branded Drugs will Increase Generic Drugs’ Market Share

    The African continent grapples with a huge burden of communicable diseases, particularly HIV/AIDS, tuberculosis, and malaria. With African governments facing major health financing challenges, a significant proportion of these disease areas are financed by global aid organizations that are also helping in poverty eradication in the continent. Paral...

    $3,000.00
  10. 04 Apr 2019  |  Asia Pacific

    Chinese Clinical Laboratories Market, Forecast to 2025

    Investment in Private and Specialty Care Clinics Drives Growth

    China is one of the fastest growing healthcare markets in the world. Traditionally, healthcare services have been dominated by the public sector; however, 2014 onward, the trend reversed with greater private sector participation. China still faces a number of challenges: unequal distribution of healthcare resources across the country; lack of an ef...

    $1,500.00